Physical Therapy Clinic Feasibility Study in Indiana

Small tickets in a deep suburban market

Indiana physical therapy lending is a small-ticket story. Across FY2017 to FY2026 the agency approved 81 loans to Indiana rehabilitation and therapy clinics, totalling $24.9 million, and the median loan of $125,000 trails the class's national median, at 0.83x. The loans in the central half sit between $50,000 and $327,600, so many of these are practice acquisitions, buy-ins and fit-outs rather than building projects. Indiana is 12 of 54 on clinic volume, and a location quotient of 1.11x means clinics claim a slightly bigger slice of Indiana lending than of the national book, even as the class sits 13 of 39 within the state. Our test finds no metric that separates this cell from both Indiana overall and clinics nationally.

Programs, lenders and places

The 7(a) programme supplied 65 of the loans and the 504 programme 16, a larger real estate share than the small median would suggest, which points to owner-occupied clinic buildings alongside the leased suites. Franchising is nearly absent at 3.7% of loans, so this is an independent-operator market. Centier Bank leads the 7(a) list with 9 loans worth $2.1 million, with First Financial Bank and The Huntington National Bank at 8 each. For 504, Premier Capital Corporation holds 7 loans worth $3.6 million and Indiana Statewide Certified Development Corporation holds 5. Hamilton County stands first with 11 loans, followed by Allen with 9, Lake with 8 and Marion with 7, which tells a lender that the northern suburbs of Indianapolis carry more clinic lending than the central county itself.

Cancellations and losses as floors

Looking at approvals made in FY2017 through FY2024, no fewer than 12.3% were later cancelled in Indiana, or 13.8% when loans still undisbursed count as cancelled. Of the 31 loans that funded between FY2017 and FY2021, 6.5% show as losses to date, and the early-years measure, losses inside the first five years, is the same 6.5%. Because every one of those losses arrived early, a lender should look hard at the first years of a clinic's ramp. Both rates are floors, since loans still open may yet be charged off, and a cohort of 31 is small enough that a single failure shifts the percentage.

What the study has to establish

A feasibility study for an Indiana clinic should measure referral supply first: the physicians, surgeons and employers within reach of the site, and the payer mix that decides what each visit earns. It should test the build-out cost against a ticket that usually lands near $125,000, and run debt service coverage on a visit ramp that allows for slow credentialing and reimbursement lag. Staffing is the other pressure point, because therapist availability caps volume regardless of demand. An appraiser valuing a practice will examine collections history or, for a startup, the credibility of the projection, so the study should show its work in a form that can be audited. Given the 1.11x concentration, competition within a short drive deserves a map rather than an assertion.